Last updated at 28 Jun 2024 04:49 AM
Director
DIN: 08414985
Nitin Pillai is currently associated with 2 companies in various capacities such as Individual Promoter and Additional Director. They serve as a Director at DURMERIC NATURACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08414985.Nitin Pillai has previously been associated with 2 companies in roles such as Additional Director and Director.Nitin Pillai is currently involved in 2 different roles. Their most recent position is with AVANZAR TECH SOLUTIONS PRIVATE LIMITED as a Additional Director. The first company Nitin Pillai was appointed to was DURMERIC NATURACEUTICALS PRIVATE LIMITED. Nitin Pillai has a status of Deactivated. Please verify the details for any specific requirements or conditions.
Nitin Pillai is currently associated with 2 companies in various capacities such as Individual Promoter and Additional Director. They serve as a Director at DURMERIC NATURACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08414985.Nitin Pillai has previously been associated with 2 companies in roles such as Additional Director and Director.Nitin Pillai is currently involved in 2 different roles. Their most recent position is with AVANZAR TECH SOLUTIONS PRIVATE LIMITED as a Additional Director. The first company Nitin Pillai was appointed to was DURMERIC NATURACEUTICALS PRIVATE LIMITED. Nitin Pillai has a status of Deactivated. Please verify the details for any specific requirements or conditions.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (2)
1y 3m 8 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| DURMERIC NATURACEUTICALS PRIVATE LIMITED | Individual Promoter | 18-Jul-2020 |
| AVANZAR TECH SOLUTIONS PRIVATE LIMITED | Additional Director | 21-Mar-2022 |